Cancer researchers look at resistance to targeted therapy in mantle cell lymphoma

(George Washington University) A team of cancer researchers at the George Washington University Cancer Center published research looking at the underlying mechanisms of resistance to the drug, Ibrutinib, which is used to treat patients with mantle cell lymphoma.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2sodN9u